Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-24-017309

EVP, Corp Strategy & Develop acquired 2,111 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2024-05-31 Grant or award +2,111 24,612 D
Derivatives
LaPlume Joseph W EVP, Corp Strategy & Develop 2024-05-31 Grant or award · Stock Options (Right to Buy) +4,797 $208.44 $999,887 4,797 D
Loading xslF345X05/form4.xml…